Literature DB >> 10705969

The influence of the cytokines Il-1beta and INFgamma on the expression of selenoproteins in the human hepatocarcinoma cell line HepG2.

K Hesse-Bähr1, I Dreher, J Köhrle.   

Abstract

Metabolic labeling of HepG2 cells with 75selenite indicated the expression of more than four selenoproteins in the 80 to 45 kDa range and more than four selenoproteins in the 24 to 14 kDa range. Although there were no significant changes in the total protein content, determined by the method of BioRad, the densitometric analysis of the autoradiogramms showed a reduced expression of all labeled selenoproteins in the cell lysates of HepG2 after cytokine treatment for 24 hours. A stronger reduction was observed after treatment with Il-1beta than with IFNgamma. Moreover, the inhibitory effects were more significant for those selenoproteins in the higher molecular mass range. Our data on the inhibition of selenoprotein synthesis and on repression of SeP promoter activity show that the expression of selenoproteins, especially of SeP, is influenced by acute phase reaction and pro-inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705969     DOI: 10.1002/biof.5520110124

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  9 in total

1.  Maternal selenium status during early gestation and risk for preterm birth.

Authors:  Margaret P Rayman; Hennie Wijnen; Huib Vader; Libbe Kooistra; Victor Pop
Journal:  CMAJ       Date:  2011-02-14       Impact factor: 8.262

2.  Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study.

Authors:  Tasnime N Akbaraly; Josiane Arnaud; Margaret P Rayman; Isabelle Hininger-Favier; Anne-Marie Roussel; Claudine Berr; Annick Fontbonne
Journal:  Nutr Metab (Lond)       Date:  2010-03-18       Impact factor: 4.169

3.  Metabolomics signature associated with circulating serum selenoprotein P levels.

Authors:  Romina di Giuseppe; Manja Koch; Ute Nöthlings; Gabi Kastenmüller; Anna Artati; Jerzy Adamski; Gunnar Jacobs; Wolfgang Lieb
Journal:  Endocrine       Date:  2018-11-17       Impact factor: 3.633

Review 4.  Pathophysiology of Non Alcoholic Fatty Liver Disease.

Authors:  Salvatore Petta; Amalia Gastaldelli; Eleni Rebelos; Elisabetta Bugianesi; Piergiorgio Messa; Luca Miele; Gianluca Svegliati-Baroni; Luca Valenti; Ferruccio Bonino
Journal:  Int J Mol Sci       Date:  2016-12-11       Impact factor: 5.923

5.  Adiposity and Serum Selenium in U.S. Adults.

Authors:  Qiuan Zhong; Ruoxi Lin; Qingjiao Nong
Journal:  Nutrients       Date:  2018-06-05       Impact factor: 5.717

6.  Total plasma magnesium, zinc, copper and selenium concentrations in type-I and type-II diabetes.

Authors:  Amélie I S Sobczak; Fiona Stefanowicz; Samantha J Pitt; Ramzi A Ajjan; Alan J Stewart
Journal:  Biometals       Date:  2019-01-22       Impact factor: 2.949

Review 7.  Associations between Circulating SELENOP Level and Disorders of Glucose and Lipid Metabolism: A Meta-Analysis.

Authors:  Ruirui Yu; Zhoutian Wang; Miaomiao Ma; Ping Xu; Longjian Liu; Alexey A Tinkov; Xin Gen Lei; Ji-Chang Zhou
Journal:  Antioxidants (Basel)       Date:  2022-06-27

Review 8.  Association between serum selenium level and type 2 diabetes mellitus: a non-linear dose-response meta-analysis of observational studies.

Authors:  Xin-Liang Wang; Tu-Bao Yang; Jie Wei; Guang-Hua Lei; Chao Zeng
Journal:  Nutr J       Date:  2016-05-04       Impact factor: 3.271

Review 9.  Selenium and selenoproteins in viral infection with potential relevance to COVID-19.

Authors:  Jinsong Zhang; Ramy Saad; Ethan Will Taylor; Margaret P Rayman
Journal:  Redox Biol       Date:  2020-09-10       Impact factor: 11.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.